Dexlansoprazole Amorphous contains not less than 98.0% and not more than 102.0% of C16H14F3N3O2S, calculated on anhydrous substance.

共有 1 個藥物證書使用此成份

右旋蘭索拉唑
Dexlansoprazole Amorphous

• 申請商: 新雙隆生技股份有限公司
• 適應症: 消化性潰瘍
• 發證日期: 2021-02-18